简介：Seeking an interferon-free regimen for HIV/HCV co-infected patients，Dr. Douglas Dieterich and colleagues have tested a combination sofosbuvir (SOF) and ribavirin (RBV) regimen to success rates of up to 88% across viral genotypes.